Literature DB >> 1891029

Erythropoietin in anemia of renal failure in sickle cell disease.

S D Roger, I C Macdougall, R C Thuraisingham, A E Raine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1891029     DOI： 10.1056/NEJM199110173251614

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  End stage renal disease in sickle cell disease: future directions.

Authors:  C R Tomson
Journal:  Postgrad Med J       Date:  1992-10       Impact factor: 2.401

2.  Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review.

Authors:  Jane A Little; Vicki R McGowan; Gregory J Kato; Kristine S Partovi; Jordan J Feld; Irina Maric; Sabrina Martyr; James G Taylor; Roberto F Machado; Theo Heller; Oswaldo Castro; Mark T Gladwin
Journal:  Haematologica       Date:  2006-08       Impact factor: 9.941

Review 3.  Renal complications of sickle cell disease: managing for optimal outcomes.

Authors:  Luciana de Santis Feltran; João Thomás de Abreu Carvalhaes; Ricardo Sesso
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

4.  Erythropoiesis-stimulating agents in sickle cell anaemia.

Authors:  Jin Han; Jifang Zhou; Vinod Kondragunta; Xu Zhang; Robert E Molokie; Michel Gowhari; Johara Hassan; Shivi Jain; Gregory S Calip; Victor R Gordeuk; Santosh L Saraf
Journal:  Br J Haematol       Date:  2017-07-27       Impact factor: 6.998

5.  Erythropoietin reduces neuronal cell death and hyperalgesia induced by peripheral inflammatory pain in neonatal rats.

Authors:  Osama Mohamad; Dongdong Chen; Lingling Zhang; Cane Hofmann; Ling Wei; Shan Ping Yu
Journal:  Mol Pain       Date:  2011-07-21       Impact factor: 3.395

Review 6.  Anemia in children with chronic kidney disease.

Authors:  Susan M Koshy; Denis F Geary
Journal:  Pediatr Nephrol       Date:  2007-01-24       Impact factor: 3.714
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.